The novel approach of the medication represents a significant advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment